Related references
Note: Only part of the references are listed.Improved MAIT cell functions following fecal microbiota transplantation for metastatic renal cell carcinoma
Marina Ninkov et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)
Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis
Satoru Yonekura et al.
CANCER DISCOVERY (2022)
Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
Dysbiosis of skin microbiome and gut microbiome in melanoma progression
Chahrazed Mekadim et al.
BMC MICROBIOLOGY (2022)
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Nazli Dizman et al.
NATURE MEDICINE (2022)
Targeting the gut and tumor microbiota in cancer
Elizabeth M. Park et al.
NATURE MEDICINE (2022)
Circulating microbiota and metabolites: Insights into cardiovascular diseases
Ikram Khan et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2022)
A phase I trial to evaluate the biologic effect of CBM588 (Clostridium butyricum) in combination with cabozantinib plus nivolumab for patients with metastatic renal cell carcinoma (mRCC).
Luis A Meza et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Dysbiosis: The first hit for digestive system cancer
Si Mei et al.
FRONTIERS IN PHYSIOLOGY (2022)
Gut microbiome in modulating immune checkpoint inhibitors
Xiang Li et al.
EBIOMEDICINE (2022)
Live bacterial supplementation for improving treatment response in metastatic renal cell carcinoma
Luis Meza et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2022)
Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
Rebecca C. Simpson et al.
NATURE MEDICINE (2022)
Polymorphic microbes: a new emerging hallmark of cancer
Mark P. Lythgoe et al.
TRENDS IN MICROBIOLOGY (2022)
Global research trends on the links between gut microbiota and cancer immunotherapy: A bibliometric analysis (2012-2021)
Shanshan Yang et al.
FRONTIERS IN IMMUNOLOGY (2022)
Targeting the gut microbiota for cancer therapy
Miriam R. Fernandes et al.
NATURE REVIEWS CANCER (2022)
Cabozantinib plus immunotherapy combinations in metastatic renal cell and urothelial carcinoma
Luis Meza et al.
FUTURE ONCOLOGY (2021)
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Erez N. Baruch et al.
SCIENCE (2021)
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Christine N. Spencer et al.
SCIENCE (2021)
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients
Diwakar Davar et al.
SCIENCE (2021)
Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion
Shintaro Okumura et al.
NATURE COMMUNICATIONS (2021)
Intestinal Microbiome Associated With Immune-Related Adverse Events for Patients Treated With Anti-PD-1 Inhibitors, a Real-World Study
Wenhui Liu et al.
FRONTIERS IN IMMUNOLOGY (2021)
The microbiome and human cancer
Gregory D. Sepich-Poore et al.
SCIENCE (2021)
Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice
Hyo Shin Yoon et al.
NATURE MICROBIOLOGY (2021)
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
Miles C. Andrews et al.
NATURE MEDICINE (2021)
The Cancer Microbiome: Recent Highlights and Knowledge Gaps
Reece J. Knippel et al.
CANCER DISCOVERY (2021)
Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?
Lisa Derosa et al.
CANCER DISCOVERY (2021)
Butyrate and the Intestinal Epithelium: Modulation of Proliferation and Inflammation in Homeostasis and Disease
Pooja S. Salvi et al.
CELLS (2021)
The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota
Stephen J. Blake et al.
CELL REPORTS MEDICINE (2021)
Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma
Nazli Dizman et al.
CANCER MEDICINE (2021)
Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota
Danfeng Chen et al.
CANCER LETTERS (2020)
Mutational signature in colorectal cancer caused by genotoxic pks+E. coli
Cayetano Pleguezuelos-Manzano et al.
NATURE (2020)
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients
Lisa Derosa et al.
EUROPEAN UROLOGY (2020)
Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer
Yusuke Tomita et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Microbiota-Derived Metabolites in Tumor Progression and Metastasis
Tania Rossi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti-PD-1 Immune Checkpoint Inhibitors
Nicholas J. Salgia et al.
EUROPEAN UROLOGY (2020)
Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease
Lingjia Kong et al.
GASTROENTEROLOGY (2020)
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma
Gianluca Ianiro et al.
NATURE COMMUNICATIONS (2020)
The gut microbiota is associated with immune cell dynamics in humans
Jonas Schluter et al.
NATURE (2020)
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial
Laurence Albiges et al.
ESMO OPEN (2020)
Clostridium butyricum Modulates the Microbiome to Protect Intestinal Barrier Function in Mice with Antibiotic-Induced Dysbiosis
Mao Hagihara et al.
ISCIENCE (2020)
An Update on Predictive Biomarkers in Metastatic Renal Cell Carcinoma
Shaan Dudani et al.
EUROPEAN UROLOGY FOCUS (2020)
Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal
Doua Azzouz et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
The microbiome, cancer, and cancer therapy
Beth A. Helmink et al.
NATURE MEDICINE (2019)
The Integrative Human Microbiome Project
Lita M. Proctor et al.
NATURE (2019)
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Jason Lloyd-Price et al.
NATURE (2019)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
L. Derosa et al.
ANNALS OF ONCOLOGY (2018)
The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease
Kassem Makki et al.
CELL HOST & MICROBE (2018)
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
David F. McDermott et al.
NATURE MEDICINE (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta-analysis
Gianluca Ianiro et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
Stereotypic Immune System Development in Newborn Children
Axel Olin et al.
CELL (2018)
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
Diana Miao et al.
NATURE GENETICS (2018)
Regulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate
Maik Luu et al.
SCIENTIFIC REPORTS (2018)
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Yinghong Wang et al.
NATURE MEDICINE (2018)
The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy
Alexandria P. Cogdill et al.
TRENDS IN IMMUNOLOGY (2018)
Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial
Toni K. Choueiri et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The Microbial Metabolite Butyrate Induces Expression of Th1-Associated Factors in CD4+ T cells
Meike Kespohl et al.
FRONTIERS IN IMMUNOLOGY (2017)
Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
Arthur E. Frankel et al.
NEOPLASIA (2017)
Novel insights into microbiome in colitis and colorectal cancer
Ye Yang et al.
CURRENT OPINION IN GASTROENTEROLOGY (2017)
Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition
Ruud S. Kootte et al.
CELL METABOLISM (2017)
The microbiome and hepatobiliary-pancreatic cancers
Kosuke Mima et al.
CANCER LETTERS (2017)
The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists
Sunil Thomas et al.
CANCER RESEARCH (2017)
Mining the Human Gut Microbiota for Immunomodulatory Organisms
Naama Geva-Zatorsky et al.
CELL (2017)
Gut Microbiota, Inflammation, and Colorectal Cancer
Caitlin A. Brennan et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 70 (2016)
Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice
Tze Guan Tan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The maternal microbiota drives early postnatal innate immune development
Mercedes Gomez de Agueero et al.
SCIENCE (2016)
Targeted Therapy and Checkpoint Immunotherapy Combinations for the Treatment of Cancer
Paul E. Hughes et al.
TRENDS IN IMMUNOLOGY (2016)
The healthy human microbiome
Jason Lloyd-Price et al.
GENOME MEDICINE (2016)
The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy
Magdalena Paolino et al.
CANCERS (2016)
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism
Douglas J. Morrison et al.
GUT MICROBES (2016)
Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome
Daniela Weber et al.
BLOOD (2015)
Novel Roles of c-Met in the Survival of Renal Cancer Cells through the Regulation of HO-1 and PD-L1 Expression
Murugabaskar Balan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
Robert J. Motzer et al.
LANCET ONCOLOGY (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
Ayelet Sivan et al.
SCIENCE (2015)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice
Hitesh S. Deshmukh et al.
NATURE MEDICINE (2014)
Control of the immune response by pro-angiogenic factors
Thibault Voron et al.
FRONTIERS IN ONCOLOGY (2014)
An estimation of the number of cells in the human body
Eva Bianconi et al.
ANNALS OF HUMAN BIOLOGY (2013)
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Yukihiro Furusawa et al.
NATURE (2013)
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Noriho Iida et al.
SCIENCE (2013)
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Sophie Viaud et al.
SCIENCE (2013)
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation
Robert R. Jenq et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
A metagenome-wide association study of gut microbiota in type 2 diabetes
Junjie Qin et al.
NATURE (2012)
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
Cora N. Sternberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A human gut microbial gene catalogue established by metagenomic sequencing
Junjie Qin et al.
NATURE (2010)
GPR109A Is a G-protein-Coupled Receptor for the Bacterial Fermentation Product Butyrate and Functions as a Tumor Suppressor in Colon
Muthusamy Thangaraju et al.
CANCER RESEARCH (2009)
Role of Tcf-DNA binding and the chromatin remodeling factor Brg-1 in the modulation of Wnt activity by butyrate
Michael Bordonaro et al.
CELL CYCLE (2008)
Specific Microbiota Direct the Differentiation of IL-17-Producing T-Helper Cells in the Mucosa of the Small Intestine
Ivaylo I. Ivanov et al.
CELL HOST & MICROBE (2008)
Host-bacterial coevolution and the search for new drug targets
Jesse Zaneveld et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
Gary Hudes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system
SK Mazmanian et al.
CELL (2005)
Cell type- and promoter-dependent modulation of the Wnt signaling pathway by sodium butyrate
M Bordonaro et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells
M Mandal et al.
GASTROENTEROLOGY (2001)
Share Paper
